# reload+after+2024-01-21 18:44:36.740670
address1§5858 Horton Street
address2§Suite 170
city§EmeryVille
state§CA
zip§94608
country§United States
phone§510 318 9098
website§https://www.estrellabio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Cheng  Liu Ph.D.', 'age': 56, 'title': 'CEO, President & Director', 'yearBorn': 1967, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.077
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§Estrella Immunopharma, Inc.
longName§Estrella Immunopharma, Inc.
firstTradeDateEpochUtc§1631626200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§aa42da4c-674b-32a3-bdaa-7ca46edb3082
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§1.281
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
